Ta strona używa pliki cookies, w celu polepszenia użyteczności i funkcjonalności oraz w celach statystycznych. Dowiedz się więcej w Polityce prywatności.
Korzystając ze strony wyrażasz zgodę na używanie plików cookies, zgodnie z aktualnymi ustawieniami przeglądarki.
Akceptuję wykorzystanie plików cookies
Central European Journal of Immunology
eISSN: 1644-4124
ISSN: 1426-3912
Central European Journal of Immunology
Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Research Gate
Search
1/2025
vol. 50
 
Share:
Send email
Share:
Original paper

Inhibition of miR-155 attenuates dendritic cell maturation and skin allograft rejection through SOCS1 in a rhesus monkey model

Qiuhong Wang
1
,
Bo Tang
1
,
Dong Wei
1
,
Dongyun Cun
1
,
Tao Wu
1
,
Renchao Zou
1
,
Tao Wang
1
,
Kun Su
1
,
Lianmin Wang
1
,
Peng Chen
1
,
Mingdao Hu
1

  1. Departments of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, China
Cent Eur J Immunol 2025; 50 (1): 52-76
DOI: https://doi.org/10.5114/ceji.2025.149439
Online publish date: 2025/05/05
Article files
- Inhibition of miR-155 (1).pdf  [5.21 MB]
- Inhibition of miR-155 - Supplementary.pdf  [0.05 MB]
Get citation
 
PlumX metrics:
 
1. Morante-Palacios O, Fondelli F, Ballestar E, Martínez-Cáceres EM (2021): Tolerogenic dendritic cells in autoimmunity and inflammatory diseases. Trends Immunol 42: 59-75.
2. Iberg CA, Hawiger D (2020): Natural and induced tolerogenic dendritic cells. J Immunol 204: 733-744.
3. Cifuentes-Rius A, Desai A, Yuen D, et al. (2021): Inducing immune tolerance with dendritic cell-targeting nanomedicines. Nat Nanotechnol 16: 37-46.
4. Chung CYJ, Ysebaert D, Berneman ZN, Cools N (2013): Dendritic cells: cellular mediators for immunological tolerance. Clin Dev Immunol 2013: 972865.
5. Li H, Shi B (2015): Tolerogenic dendritic cells and their applications in transplantation. Cell Mol Immunol 12: 24-30.
6. Xia MJ, Shan J, Ping Li Y, et al. (2013): Adoptive transfusion of tolerant dendritic cells prolong the survival of renal allografts: a systematic review. J Evid Based Med 6: 250-264.
7. Xia MJ, Shan J, Ping Li Y, et al. (2014): Adoptive transfusion of tolerogenic dendritic cells prolongs the survival of liver allograft: a systematic review. J Evid Based Med 7: 135-146.
8. Wu W, Shan J, Li Y, et al. (2012): Adoptive transfusion of tolerance dendritic cells prolongs the survival of cardiac allograft: a systematic review of 44 basic studies in mice. J Evid Based Med 5: 139-153.
9. Rama I, Bruene B, Torras J, et al. (2008): Hypoxia stimulus: An adaptive immune response during dendritic cell maturation. Kidney Int 73: 816-825.
10. Perez CR, De Palma M (2019): Engineering dendritic cell vaccines to improve cancer immunotherapy. Nat Commun 10: 5408.
11. Ivey KN, Srivastava D (2010): MicroRNAs as regulators of differentiation and cell fate decisions. Cell Stem Cell 7: 36-41.
12. Mehta A, Baltimore D (2016): MicroRNAs as regulatory elements in immune system logic. Nat Rev Immunol 16: 279-294.
13. Turner ML, Schnorfeil FM, Brocker T (2011): MicroRNAs regulate dendritic cell differentiation and function. J Immunol 187: 3911-3917.
14. Hu J, Huang S, Liu X, et al. (2022): miR-155: an important role in inflammation response. J Immunol Res 2022: 7437281.
15. Thai TH, Patterson HC, Pham DH, et al. (2013): Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the Fas lpr mouse. Proc Natl Acad Sci 110: 20194-20199.
16. Lu C, Huang X, Zhang X, et al. (2011): miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 117: 4293-4303.
17. Zhou H, Huang X, Cui H, et al. (2010): miR-155 and its star-form partner miR-155* cooperatively regulate type I interferon production by human plasmacytoid dendritic cells. Blood 116: 5885-5894.
18. Martinez-Nunez RT, Louafi F, Friedmann PS, et al. (2009): MicroRNA-155 modulates the pathogen binding ability of dendritic cells (DCs) by down-regulation of DC-specific intercellular adhesion molecule-3 grabbing non-integrin (DC-SIGN). J Biol Chem 284: 16334-16342.
19. Rodriguez A, Vigorito E, Clare S, et al. (2007): Requirement of bic/microRNA-155 for normal immune function. Science 316: 608-611.
20. Zheng Z, Yang Y, Liu H, et al. (2022): Inhibition of miR-let-7i induces DC immature cells and improves skin graft tolerance. Dis Markers 2022: 8605621.
21. Etra JW, Grzelak MJ, Fidder SAJ, et al. (2019): A skin rejection grading system for vascularized composite allotransplantation in a preclinical large animal model. Transplantation 103: 1385.
22. Cendales L, Kanitakis J, Schneeberger S, et al. (2008): The Banff 2007 working classification of skin-containing composite tissue allograft pathology. Am J Transplant 8: 1396-1400.
23. Kalkusova K, Taborska P, Stakheev D, et al. (2022): The role of miR-155 in antitumor immunity. Cancers 14: 5414.
24. Yao R, Ma YM, Liang W, et al. (2012): MicroRNA-155 modulates Treg and Th17 cells differentiation and Th17 cell function by targeting SOCS1. PLoS One 7: e46082.
25. Heyn J, Luchting B, Hinske LC, et al. (2016): miR-124a and miR-155 enhance differentiation of regulatory T cells in patients with neuropathic pain. J Neuroinflammation 13: 248.
26. Schjenken JE, Moldenhauer LM, Zhang B, et al. (2020): MicroRNA miR-155 is required for expansion of regulatory T cells to mediate robust pregnancy tolerance in mice. Mucosal Immunol 13: 609-625.
27. Spoerl D, Duroux-Richard I, Louis-Plence P, et al. (2013): The role of miR-155 in regulatory T cells and rheumatoid arthritis. Clin Immunol 148: 56-65.
28. Dunand-Sauthier I, Santiago-Raber ML, Capponi L, et al. (2011): Silencing of c-Fos expression by microRNA-155 is critical for dendritic cell maturation and function. Blood 117: 4490-4500.
29. Lind EF, Millar DG, Dissanayake D, et al. (2015): miR-155 upregulation in dendritic cells is sufficient to break tolerance in vivo by negatively regulating SHIP1. J Immunol 195: 4632-4640.
30. Banerjee A, Schambach F, DeJong CS, et al. (2010): Micro-RNA-155 inhibits IFN- signaling in CD4+ T cells. Eur J Immunol 40: 225-231.
31. Thomson AW, Ezzelarab MB (2018): Regulatory dendritic cells: profiling, targeting and therapeutic application. Curr Opin Organ Transplant 23: 538-545.
32. Divito SJ, Wang Z, Shufesky WJ, et al. (2010): Endogenous dendritic cells mediate the effects of intravenously injected therapeutic immunosuppressive dendritic cells in transplantation. Blood 116: 2694-2705.
33. Chen L, Gao D, Shao Z, et al. (2020): miR-155 indicates the fate of CD4+ T cells. Immunol Lett 224: 40-49.
34. Yoshimura A, Ito M, Mise-Omata S, et al. (2021): SOCS: negative regulators of cytokine signaling for immune tolerance. Int Immunol 33: 711-716.
35. Klaver EJ, Kuijk LM, Lindhorst TK, et al. (2015): Schistosoma mansoni soluble egg antigens induce expression of the negative regulators SOCS1 and SHP1 in human dendritic cells via interaction with the mannose receptor. PLoS One 10: e0124089.
36. Wang D, Tang M, Zong P, et al. (2018): MiRNA-155 regulates the Th17/Treg ratio by targeting SOCS1 in severe acute pancreatitis. Front Physiol 9: 686.
37. Takahashi R, Yoshimura A (2014): SOCS1 and regulation of regulatory T cells plasticity. J Immunol Res 2014: 943149.
38. Tamiya T, Kashiwagi I, Takahashi R, et al. (2011): Suppressors of cytokine signaling (SOCS) proteins and JAK/STAT pathways: regulation of T-cell inflammation by SOCS1 and SOCS3. Arterioscler Thromb Vasc Biol 2011; 31: 980-985.
39. Diehl S, Anguita J, Hoffmeyer A, et al. (2000): Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13: 805-815.
Copyright: © 2025 Polish Society of Experimental and Clinical Immunology This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2025 Termedia Sp. z o.o.
Developed by Bentus.